1 result
  • CIRT

    A randomized clinical trial investigating whether taking low-dose methotrexate reduces heart attacks, strokes, or death in people with type 2 diabetes or metabolic syndrome that have had a heart attack or multiple coronary blockages.

    Type: Drug trial

    Principal Investigator: John B. Kostis, MD

    Trial is open for enrollment

    For inquiries, call (732) 235-6546
    • Rutgers Robert Wood Johnson Medical School
    • Robert Wood Johnson University Hospital